bpc 157 human clinical trials randomized double blind Frontiers Efficacy, safety, and tolerability of
Description
Common variable immune deficiency, central diabetes insipidus, and anemia
The research is consistent
[PMC free article: PMC3985831] [PubMed: 24598885] 24
Here are some key considerations: Allergic Reactions : If you have a history of allergic reactions to cobalt, cyanocobalamin, or any other ingredients in the injection, inform your healthcare provider before starting treatment
